R.SR
REGISTERED-SUPPLEMENTAL REGISTER
02/15/2022
Back to search
Official data from USPTO
BIOLOGICS RARE AND ORPHAN CARE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
BIOLOGICS RARE AND ORPHAN CARE
ST13
US500000090482182Class
44, 45
Filing
90482182
Registration
6648633
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
18
Latest update
02/15/2022
Trademark type
Word
Nice classes
44, 45
Filing date
01/22/2021
Registration date
02/15/2022
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
02/15/2022
Last transaction
02/15/2022
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Supplemental Register
Filing basis
Intent to use
First use anywhere
2020-08-00
First use in commerce
01/31/2021
Drawing code
4
Owner type
03
Owner location
Irving, TX
Examiner
QUEEN, ESTHER
Law office
M20
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
M. C. (pessoa física)
Representatives
Auma N. Reggy MCKESSON CORPORATION
Technical classification
Nice Classes
Class 44Class 45
Vienna Codes
No Vienna codes available.
Goods and services
Class 44
Dispensing of pharmaceuticals in the rare and orphan therapeutic areas; providing pharmaceutical advice in the field of delivery of oncology and rare and orphan drugs; medical counselingcounseling for patients with cancer and other rare and orphan conditions to ensure safety and compliance in taking oncology and other highly complex rare specialty drugs; dispensing of pharmaceuticals in oncology and other rare and orphan therapeutic fields; dispensing of medications; consulting services in the field of health provided to cliniciansbiopharmalife science companiesresearchers and payors to help monitor and achieve positive outcomes for patients
Class 45
Providing patient case management assistance servicescoordinating the procurement and administration of complex and high-cost rare and orphan specialty medications
Publications
History of USPTO decisions and trademark events.
18 publications found
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
01/12/2022
ALIE
ASSIGNED TO LIE
01/12/2022
CNTA
APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
01/11/2022
AAUA
NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED
01/11/2022
IUAA
USE AMENDMENT ACCEPTED
01/08/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
11/20/2021
AUPC
AMENDMENT TO USE PROCESSING COMPLETE
11/20/2021
IUAF
USE AMENDMENT FILED
11/20/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
11/19/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
11/19/2021
EAAU
TEAS AMENDMENT OF USE RECEIVED
11/19/2021
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
05/19/2021
GNRT
NON-FINAL ACTION E-MAILED
05/19/2021
CNRT
NON-FINAL ACTION WRITTEN
05/19/2021
DOCK
ASSIGNED TO EXAMINER
05/14/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
04/23/2021
NWAP
NEW APPLICATION ENTERED
01/26/2021
Continuous trademark protection
Get notified about every new filing that threatens BIOLOGICS RARE AND ORPHAN CARE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.